DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo



197.39 -1.99 (-1.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACT $197.39 -1.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $198.49
Previous Close $199.38
Daily Range $195.37 - $200.88
52-Week Range $96.52 - $230.77
Market Cap $34.4B
P/E Ratio -37.46
Dividend (Yield) $0.00 (0.0%)
Volume 1,522,676
Average Daily Volume 2,865,230
Current FY EPS $13.03





ACTAVIS (ACT) Description

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Website:

News & Commentary

Is This Drug Maker’s Stock Too Cheap to Ignore?

Teva Pharmaceutical shares have under performed its sector over the past year. Though the company faces a number of issues, most of the bad news may already be priced into the stock. Given the drug maker also appears to have some intriguing opportunities for future growth, are Teva shares too cheap to ignore?

Impax to Sell Authorized Generic Renvela - Analyst Blog

Actavis to Acquire Four Products from Akorn; Terms Undisclosed

Zacks Rank #1 Additions for Thursday - Tale of the Tape

MYL, FRX And ACT, 3 Drugs Stocks Pushing The Industry Lower

Hidden Australian Life Sciences Growth Stocks Revealed: Scott Power

Sterne Agee Sees 16% Upside for Actavis, Initiates Coverage

Mylan Inks Two Separate Agreements - Analyst Blog

Benzinga's Top Initiations

Acura Pharma Ends Agreement with Pfizer - Analyst Blog

Acura Pharma Ends Agreement with Pfizer - Analyst Blog

3 Health Care Stocks Moving The Sector Upward

See More ACT News...

ACT's Top Competitors

ACT $197.39 (-1.00%)
Current stock: ACT
JNJ $98.96 (0.21%)
Current stock: JNJ
NVS $84.67 (0.31%)
Current stock: NVS
RHHBY $36.22 (0.14%)
Current stock: RHHBY